For over a decade, LSX Europe has brought together the leaders shaping the future of life sciences - and in 2026, we take the Congress to Lisbon for the very first time.
It unites the founders and CEOs of early to late stage biotechs, medtechs and healthtechs with global investors, pharma and the partners driving innovation forward.

Lisbon marks an exciting new chapter for LSX Europe.
By aligning with our sister event Bio-Europe Spring, we’re creating a single, unified European Life Science Week (Spring Innovation Week) - maximising investment and partnering engagement in one high-impact week.
Co-location brings more investors, partners and dealmakers into one city, delivering greater opportunities for networking, business development and visibility for everyone involved.

Swiss Biotech Association member can get an 15% discount on their ticket. If interested, members should reach out to us.